1 Min Read
Feb 23 (Reuters) - Celltrion Inc :
* Says it signed a 56.8 billion won contract with Celltrion Healthcare co.,Ltd to sell bio-similar antibody drug
Source text in Korean: goo.gl/GKxH4w
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.